Keystone 2006. Steady progress presented and discussed at the annual Keystone Symposia on HIV.
Kresge
Kristen Jill
KJ
Noble
Simon
S
D000071480:APOBEC-3G Deaminase; D000818:Animals; D000090103:Antiviral Restriction Factors; D018414:CD8-Positive T-Lymphocytes / Q000502:physiology; D002352:Carrier Proteins / Q000502:physiology; D016665:Cercocebus atys; D003564:Cytidine Deaminase; D004279:DNA, Viral / Q000502:physiology; D006678:HIV / Q000235:genetics / Q000502:physiology; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D008212:Lymphocyte Depletion; D009700:Nucleoside Deaminases / Q000502:physiology; D012367:RNA, Viral / Q000502:physiology; D012097:Repressor Proteins / Q000502:physiology; D000070584:Tripartite Motif Proteins; D044767:Ubiquitin-Protein Ligases; D014779:Virus Replication
D000090103:Antiviral Restriction Factors; D002352:Carrier Proteins; D004279:DNA, Viral; D012367:RNA, Viral; D012097:Repressor Proteins; D000070584:Tripartite Motif Proteins; C477346:TRIM5 protein, human; D044767:Ubiquitin-Protein Ligases; D009700:Nucleoside Deaminases; D000071480:APOBEC-3G Deaminase; C464924:APOBEC3G protein, human; D003564:Cytidine Deaminase